Relay Therapeutics, Inc. · NASDAQ:RLAY
Catinazzo Thomas sold 19,517 Relay Therapeutics, Inc. shares (Form 4)
Traded Apr 7 to Apr 9, 2026 · Filed Apr 9, 2026
From Apr 7 to Apr 9, 2026, Catinazzo Thomas (Chief Financial Officer) sold 19,517 Relay Therapeutics, Inc. shares at an average US$13.19 for US$257K under a trading plan, leaving 213,867 shares. Filed Apr 9, 2026 (Form 4).
- Sold
- 19,517 shares
- Price
- US$13.19 average (US$13.01 to US$15.00)
- Value
- US$257K
- Holding after
- 213,867 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Common Stock | Sale | 17,717 | US$13.01 | 213,867 | Direct |
| Apr 9, 2026 | Common Stock | Option exercise | 1,800 | US$5.22 | 215,667 | Direct |
| Apr 9, 2026 | Common Stock | Sale | 1,800 | US$15.00 | 213,867 | Direct |
Source
Related
- Relay Therapeutics, Inc.
- Catinazzo Thomas
- Relay Therapeutics, Inc. shareholders
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Aug 18, 2026
- Form 4 · Catinazzo Thomas · Jul 30, 2026
- Form 4 · Catinazzo Thomas · Jul 8, 2026
- Form 4 · Patel Sanjiv · Oct 8, 2026
- Form 4 · Bergstrom Donald A · Sep 9, 2026
- Form 4 · Patel Sanjiv · Sep 9, 2026
- Form 4 · Rahmer Peter · Aug 28, 2026
- Form 4 · Sb Investment Advisers (UK) LTD · Aug 28, 2026